Share This

PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
FDA Clearance For Gastrointestinal Parasite Detection Kit
MELBOURNE, Australia , June 4, 2024 /PRNewswire/ -- G enetic Signatures Limited [ASX:GSS] ("GSS" or the "Company") , a global molecular diagnostics company announces that the ...
2024-06-04T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Angel Yeast Partners with BakeMark Launching Multiple Product Lines at Bakery China 2024
SHANGHAI , June 4, 2024 /PRNewswire/ -- Angel Yeast , (SH600298), the world's leading yeast manufacturer, joined hands with BakeMark to unveil a variety of product lines under the name BakeMark By ...
2024-06-04T    Biotechnology   Environmental Products & Services   Food/Beverages   Green Technology 
MicroAlgo Inc. (NASDAQ: MLGO) Announced to Jointly Establish a Micro-Consciousness Quantum Research Center With WIMI (NASDAQ: WIMI)
BEIJING , June 4, 2024 /PRNewswire/ -- MicroAlgo Inc. (NASDAQ: MLGO) (the "Company" or "MicroAlgo"), today announced that MicroAlgo and WiMi will jointly establish a micro-consciousness ...
2024-06-04T    Biotechnology   Computer Software   Computer/Electronics 
AmpleLogic Launches Advanced aPaaS for Life Sciences with 14 Ready-to-Use Applications
HYDERABAD, India , June 4, 2024 /PRNewswire/ -- AmpleLogic, a leading provider of GAMP solutions, announces the launch of its revolutionary Application Platform as a Service (aPaaS) designed specifically ...
2024-06-04T    Biotechnology   Computer Software   Computer/Electronics   Health Care/Hospital 
GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings
YONGIN, South Korea , June 4, 2024 /PRNewswire/ -- GC Biopharma announced that it will attend 2024 Spring Symposium of the Korean American Society in Biotech and Pharmaceuticals (KASBP) on June ...
2024-06-04T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Fapon Biopharma Announces a Safer Immunotherapy for Cancers
SAN DIEGO , June 4, 2024 /PRNewswire/ -- At Bio International Convention 2024, which is taking place here in San Diego during June 3-6 , Fapon Biopharma, an innovator in developing therapeutic antibodies ...
2024-06-04T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
RemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88
YANTAI, China , June 4, 2024 /PRNewswire/ --  RemeGen Co., Ltd.  ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, presented ...
2024-06-04T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Built by Nature Prize Awards €500,000 to Biobased Construction Innovators
AMSTERDAM , June 4, 2024 /PRNewswire/ -- Built by Nature is pleased to announce the winners of its inaugural global Prize to stimulate uptake of innovative biobased construction materials, ...
2024-06-04T    Biotechnology   Construction/Building   Environmental Products & Services   Green Technology 
BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx
ADELAIDE , South Australia , June 3, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced the exclusive rights to ...
2024-06-03T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Datasea Agreement already provided $2.8 million Information Service for its Highly Specialized 5G-AI Communications Platform
Agreement to Have Powerful Revenue Impact and is Expected to Lead to More Lucrative Contracts ...
2024-06-03T    Banking/Financial Service   Biotechnology   Computer/Electronics   Health Care/Hospital 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.